Our Services
Medical Information
Helpful Resources
Published on: 4/29/2026
Platelet rich plasma is a regenerative therapy for Crohn’s that may enhance mucosal healing, modulate inflammation, and support fistula closure when conventional therapies fall short. Early studies and off label protocols show promising safety and effectiveness, although larger trials are needed to define optimal dosing and long term outcomes.
There are several factors to consider, so see important details below to guide your next steps with specialists and clinical trials.
Crohn's disease is a chronic inflammatory bowel disease (IBD) that can cause abdominal pain, diarrhea, weight loss, and complications such as fistulas or strictures. While conventional treatments—like aminosalicylates, corticosteroids, immunomodulators, and biologics—help many people, some patients continue to struggle with persistent symptoms or complications. This has led researchers and clinicians to explore regenerative approaches, including platelet-rich plasma (PRP) therapy.
In this article, we'll explain:
Throughout, we'll use clear language, avoid unnecessary alarm, and guide you toward trusted medical advice.
Platelet-rich plasma (PRP) is a concentrated solution of a person's own platelets suspended in a small volume of plasma. Platelets are well known for helping blood clot, but they also contain dozens of growth factors and signaling molecules that can:
To prepare PRP, a small blood sample is spun in a centrifuge to separate red blood cells and concentrate platelets. The resulting PRP can be injected directly into damaged tissues or applied during surgical procedures.
Key growth factors in PRP:
By delivering this potent mix locally, PRP aims to enhance the body's natural healing processes.
PRP is most commonly used in orthopedics (e.g., tendon injuries) and dermatology (e.g., hair restoration). However, the principles of tissue repair and inflammation control have led investigators to study PRP in gastrointestinal conditions, notably:
Research into PRP for Crohn's disease is still emerging. Here's a summary of the most credible findings:
Animal Studies
Small Human Trials & Case Series
Regulatory Standing
Safety Profile
Limitations of Current Data
Not every person with Crohn's disease is a candidate for PRP. Ideal situations include:
Before considering PRP, you should:
Use a Free AI-Powered Symptom Checker
If you're experiencing persistent digestive symptoms and want to understand whether they might be related to Crohn's Disease, a free AI-powered symptom checker can help you identify key warning signs and determine when to seek professional medical evaluation.
Gather Your Medical Records
Seek a Specialist Consultation
Review Clinical Trials
Discuss Insurance and Costs
Develop a Comprehensive Care Plan
PRP for Crohn's disease represents an exciting frontier, but it is not a miracle cure. Key points to keep in mind:
By staying informed and proactive, you can weigh the potential benefits of PRP against its experimental status.
While PRP is generally safe, Crohn's disease itself can lead to life-threatening complications. Contact your doctor or go to the emergency room if you experience:
Always err on the side of caution and speak to a doctor about any alarming or worsening symptoms.
Platelet-rich plasma (PRP) offers a novel, biologically based approach to supporting tissue repair and modulating inflammation in Crohn's disease, especially for challenging complications like perianal fistulas. While high-quality data are still accumulating, early studies suggest that PRP may:
If you're curious whether PRP for Crohn's disease might be right for you, start by using a free AI-powered symptom checker for Crohn's Disease to better understand your symptoms, then gather your medical history and speak with a gastroenterologist. They can help you explore clinical trials, navigate off-label protocols, and ensure any intervention fits safely into your overall care plan.
Remember: nothing in this article replaces professional medical advice. Always consult your healthcare provider before starting or changing treatments for Crohn's disease.
(References)
* Al-Saadi, R., Al-Hashimi, S., & Hussain, M. (2023). Efficacy of platelet-rich plasma in inflammatory bowel disease: A systematic review and meta-analysis. World Journal of Gastroenterology, 29(45), 6125–6136. doi: 10.3748/wjg.v29.i45.6125
* Liao, J., Liang, C., Fu, Z., Han, C., & Zhang, J. (2022). Mesenchymal stem cell and platelet-rich plasma treatments for refractory Crohn's perianal fistula: a systematic review and meta-analysis. Surgical and Radiologic Anatomy, 44(6), 757–770. doi: 10.1007/s00276-022-02943-7
* Gubrij, R., Zivkovic, A., Ignjatovic, M., Bumbasirevic, V., Stojkovic, A., Vujic, A., ... & Bumbasirevic, U. (2023). Platelet-rich plasma as a new therapeutic tool for inflammatory bowel disease. Vojnosanitetski Pregled, 80(7), 652–658. doi: 10.2298/VSP2307652G
* Chuang, Y. L., Chen, Y. C., Hsu, R. W., Lin, C. M., & Yeh, C. T. (2021). Growth factors in platelet-rich plasma and their potential application in inflammatory bowel disease. Frontiers in Immunology, 12, 703534. doi: 10.3389/fimmu.2021.703534
* Koukias, I., Nikolaou, A., Skotini, E., Mantas, G., Roussos, A., Vrakas, S., & Papalambros, A. (2024). Topical platelet-rich plasma for the treatment of rectovaginal fistula in Crohn's disease: A pilot study. Journal of Clinical Medicine, 13(3), 670. doi: 10.3390/jcm13030670
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.